Aspirin 100 mg + Placebo
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
High-Normal Blood Pressure
Conditions
High-Normal Blood Pressure, Mild Essential Hypertension
Trial Timeline
Jan 1, 2007 → Dec 1, 2008
NCT ID
NCT00449618About Aspirin 100 mg + Placebo
Aspirin 100 mg + Placebo is a approved stage product being developed by Bayer for High-Normal Blood Pressure. The current trial status is terminated. This product is registered under clinical trial identifier NCT00449618. Target conditions include High-Normal Blood Pressure, Mild Essential Hypertension.
Hype Score Breakdown
Clinical
20
Activity
0
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00449618 | Approved | Terminated |